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Charts and tables in coronary risk prevention
In the article by Jones and colleagues published recently in Heart, eight methods, which have been proposed for CHD (or cardiovascular disease) risk prediction, were compared in a population of patients whose general practitioners wished to assess risk. 11 The methods were all based on the Framingham risk equation, because this remains the only published epidemiological study in which there are both men and women and in which a reasonably comprehensive range of risk factors was measured. 12 The overall best method in terms of how closely its results matched the original equation was the Joint British Societies coronary risk prediction charts, 2 13 which is gratifying to those of us who designed them, coming as it does from an independent source. The need for the Joint British Societies charts was created by the inaccuracy in the SheYeld tables, 14 which was unknown until they were subjected to clinical trial. 8 Unfortunately by then their use had been advised by the standing medical advisory committee (SMAC) to the chief medical oYcer of health. 15 The New Zealand charts, 16 which were recommended by SMAC as a possible alternative to the SheYeld tables, are also revealed by the study by Jones and colleagues 11 to be less accurate than the Joint British Societies charts. So also are the European ones. 6 These findings are confirmed by our own unpublished results in the population, which we previously studied in the evaluation of the NCEP algorithm, the European charts, and the original SheYeld tables 8 (table 1) . The Joint British Societies charts are available as a leaflet or as a wall chart from the British Heart Foundation (telephone 020 7487 7142) and are to be found at the back of the British National Formulary.
HDL cholesterol and primary prevention
It is particularly important to note that the study of Jones and colleagues 11 once again underlines the importance of measuring high density lipoprotein (HDL) cholesterol as well as total serum cholesterol in the assessment of risk in primary prevention. This is because, as risk factors multiply, HDL cholesterol concentrations fall (fig 1) . Thus the people who are at most risk often fail to be identified unless the additional risk from their low HDL cholesterol is taken into account. 8 The necessity to measure HDL cholesterol is made more emphatic in Britain by the high level of risk which is being advocated before statins can be employed. This is because the inaccuracy of predicting CHD risk without measuring HDL cholesterol becomes progressively greater as higher risk groups are targeted (fig 2) . It is probably not widely enough appreciated that the measurement of HDL cholesterol can be undertaken on nonfasting samples 2 (unlike the measurement of triglycerides Coronary heart disease risk was calculated using the Framingham risk equation 12 except in the case of the New Zealand charts when cardiovascular risk, which they are designed to predict, was calculated. The percentages are for the patients (n) to whom the charts or tables could be applied.
or of low density lipoprotein (LDL) cholesterol when this is calculated, as it is in most laboratories, from the fasting triglycerides, serum cholesterol, and HDL cholesterol). It is not generally necessary, however, to measure HDL cholesterol in secondary prevention (when a serum cholesterol of 5.00 mmol/l or greater is taken as the indication for statin treatment) nor in the monitoring of patients once the decision to introduce such treatment has been taken. 2 
Computer assisted risk prediction
The results of Jones and colleagues 11 indicate that further development in chart design is unlikely. The only improvement possible is for the clinician to use a computer programme to calculate CHD risk. The Joint British Societies' recommendations already recognise this, which is why the "Cardiac risk assessor" computer program was issued with each of the Heart supplements containing the recommendations. 2 The program is also available from the British Heart Foundation and from the present authors, and it is on the British Hypertension Society website (www.hyp.ac.uk/bhs) and the British National Formulary website (http://bnf.org). In addition to the information provided by the charts, the computer program also allows left ventricular hypertrophy to be taken into account and provides both coronary and stroke risk based on systolic and diastolic blood pressures. 
